Literature DB >> 1636149

Long-term frontal brain metabolic changes in cocaine abusers.

N D Volkow1, R Hitzemann, G J Wang, J S Fowler, A P Wolf, S L Dewey, L Handlesman.   

Abstract

Neurological complications from cocaine use are well recognized. We propose that chronic cocaine use can also cause clinically silent brain dysfunction. We investigated brain glucose metabolism with positron emission tomography (PET) and 2-deoxy-2[18F] fluoro-D-glucose (FDG) in 21 neurologically intact chronic cocaine abusers (C) and 18 normal controls (N). The cocaine abusers were tested 1-6 weeks after the last use of cocaine and seven were retested after a 3 month drug-free period. Global cerebral glucose metabolism was not significantly different between controls and cocaine abusers (N = 38.4 +/- 3, C = 36.5 +/- 5 mumol/100 g of tissue, min). However, cocaine abusers had significantly (P less than 0.05) lower metabolic activity in 16 of the 21 left frontal regions and 8 of the 21 right frontal regions. These decreases persisted after 3-4 months of detoxification and were correlated with the dose (P less than or equal to 0.01) and the years of cocaine use (P less than or equal to 0.05). This study shows reduced rates of frontal metabolism in neurologically intact cocaine abusers that persist even after 3-4 months of detoxification.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1636149     DOI: 10.1002/syn.890110303

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  108 in total

1.  fMRI response in the medial prefrontal cortex predicts cocaine but not sucrose self-administration history.

Authors:  Hanbing Lu; Svetlana Chefer; Pradeep K Kurup; Karine Guillem; D Bruce Vaupel; Thomas J Ross; Anna Moore; Yihong Yang; Laura L Peoples; Elliot A Stein
Journal:  Neuroimage       Date:  2012-06-01       Impact factor: 6.556

Review 2.  The addicted human brain: insights from imaging studies.

Authors:  Nora D Volkow; Joanna S Fowler; Gene-Jack Wang
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 3.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

Review 4.  Neuroimaging in drug abuse.

Authors:  Kimberly P Lindsey; S John Gatley; Nora D Volkow
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

Review 5.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

Review 6.  Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.

Authors:  M Foster Olive
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

7.  Effects of cocaine rewards on neural representations of cognitive demand in nonhuman primates.

Authors:  Robert E Hampson; Linda J Porrino; Ioan Opris; Terrence Stanford; Sam A Deadwyler
Journal:  Psychopharmacology (Berl)       Date:  2010-09-24       Impact factor: 4.530

Review 8.  [CNS metabolism in high-risk drug abuse, German version : Insights gained from 1H- and 31P MRS and PET].

Authors:  S V Bodea
Journal:  Radiologe       Date:  2017-06       Impact factor: 0.635

9.  Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence.

Authors:  D Tomasi; R Z Goldstein; F Telang; T Maloney; N Alia-Klein; E C Caparelli; N D Volkow
Journal:  Brain Res       Date:  2007-08-10       Impact factor: 3.252

Review 10.  Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.

Authors:  Valentina Berti; Lisa Mosconi; Alberto Pupi
Journal:  PET Clin       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.